<PAGE>
|--------------------------|
| OMB APPROVAL |
| ------------ |
| OMB Number 3235-0058 |
| Expires June 30, 1991 |
| Average estimated burden |
| hours per response 2.50|
----------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
|---------------------------|
| SEC FILE NUMBER |
| 1-11239 |
-----------------------------
NOTIFICATION OF LATE FILING
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
|--------------------------|
| CUSIP NUMBER |
| 197677-10-7 |
----------------------------
For Period Ended: December 31, 1994
-----------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transaction Period Ended:_______________________________________
|------------------------------------------------------------------------------|
| Nothing in this form shall be construed to imply that the Commission has |
| verified any information contained herein. |
- --------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
Filing of definitive proxy materials to include Part III information on Form
10-K.
- --------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
Columbia/HCA Healthcare Corporation
- --------------------------------------------------------------------------------
Full Name of Registrant
- --------------------------------------------------------------------------------
Former Name if Applicable
One Park Plaza
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Nashville, Tennessee 37203
- --------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
(a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
| (b) The subject annual report, semi-annual report, transition report
| on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,
[X]| will be filed on or before the fifteenth calendar day following
| the prescribed due date; or the subject quarterly report of
| transition report on Form 10-Q, or portion thereof will be filed
on or before the fifth calendar day following the prescribed due
date; and
(c) The accountant's statement or other exhibit required by Rule 12b-
25(c) has been attached if applicable.
<PAGE>
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q, N-
SAR, or the transition report or portion thereof, could not be filed within the
prescribed time period. (Attach Extra Sheets if Needed)
Columbia/HCA Healthcare Corporation ("Columbia") filed its 1994 Annual Report on
Form 10-K on March 31, 1995. Such annual report did not include certain Part III
information. Between the time that Columbia filed its Annual Report on Form 10-K
and May 1, 1995, the date which Columbia anticipated filing its definitive proxy
materials containing the relevant Part III information, Columbia moved its
annual meeting of stockholders from May 12, 1995 to June 8, 1995, in an effort
to include the stockholders of Healthtrust, Inc. - The Hospital Company
("Healthtrust"), in the mailing of proxy materials (Columbia acquired
Healthtrust in a $3.2 billion merger transaction which closed on April 24, 1995,
several weeks later than anticipated). Due to the delay of the closing of the
Healthtrust transaction, the unavailability of certain updated information
regarding Healthtrust and the addition of three new directors to the Columbia
board as a result of the Healthtrust transaction, Columbia did not file its
definitive proxy materials by May 1, 1995 and inadvertently did not file an
amendment to its Form 10-K to complete the Part III information within the 120
days specified in Instruction G to Form 10-K. Columbia is prepared to file the
definitive proxy materials (which includes the Part III information ) on or
before May 5, 1995.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification:
Stephen T. Braun, Esq. (502) 572-2180
----------------------- ----------- ---------------------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under [X] Yes [ ] No
Section 13 or 15(d) of the Securities Exchange Act of
1934 or Section 30 of the Investment Company Act of 1940
during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports)
been filed? If answer is no, identify report(s).
(3) Is it anticipated that any significant change in results [ ] Yes [X] No
of operations from the corresponding period for the last
fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof?
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
- -------------------------------------------------------------------------------
Columbia/HCA Healthcare Corporation
----------------------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: May 3, 1995 By: /s/ Stephen T. Braun
-------------- ------------------------------------------
Stephen T. Braun
Senior Vice President and General Counsel
